$24.81
+1.74 (+7.54%)
Performance
1D
—
1W
—
1M
—
3M
+126.16%
6M
+528.10%
1Y
+404.27%
YTD
+177.05%
Open$23.47
Previous Close$23.07
Day High$24.94
Day Low$23.44
52W High$30.60
52W Low$2.76
Volume—
Avg Volume1.29M
Market Cap3.16B
P/E Ratio—
EPS$-3.85
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$19.51
Above
SMA 200
$8.26
Above
RSI (14)
60.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
-1.2% upside
Current
$24.81
$24.81
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 878.33M | 917.39M | 923.52M |
| Net Income | 120.27M | 166.79M | 141.53M |
| Profit Margin | 13.7% | 18.2% | 15.3% |
| EBITDA | 272.46M | 241.94M | 249.41M |
| Free Cash Flow | 126.96M | 147.40M | 173.90M |
| Rev Growth | +6.0% | +16.1% | -7.6% |
| Debt/Equity | 0.25 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |